Neumora Therapeutics, Inc. - Common Stock (NMRA)

$9.42 0.39 (3.98%)

16:00 EDT NMRA Stock Quote Delayed 30 Minutes

NMRA Stock Earnings: Neumora Therapeutics Meets EPS for Q1 2024

By InvestorPlace Earnings May 7, 2024

NMRA stock results show that Neumora Therapeutics met analyst estimates for earnings per share the first quarter of 2024.

Why Is Neumora Therapeutics (NMRA) Stock Down 25% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

NMRA Stock Earnings: Neumora Therapeutics Misses EPS for Q4 2023

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 428,339

Day's Range $9.13 - $9.82

52-Week Range $8.82 - $21.00

Dividend & Yield N/A (N/A)

NMRA Stock Predictions, Articles, and Neumora Therapeutics, Inc. - Common Stock News

From InvestorPlace
From the Web

7 Stocks with Strong Insider Buying: December 2023

By Chris Markoch, InvestorPlace Contributor Dec 17, 2023

Stocks with strong insider buying should make you curious, and finding them can be a useful shortcut for your research

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Nov 30, 2023

It's time for a breakdown of the biggest pre-market stock movers as we check out all of the hottest news on Thursday morning!

Ticking Time Bombs: 3 New Stocks to Dump Before the Damage Is Done (IPO)

By Tyrik Torres, InvestorPlace Contributor Sep 28, 2023

The IPO market in 2023 has been anything but hot. After a record-breaking year in 2021, the appetite for new listings has cooled down significantly,…

Neumora Tumbles as Early-Stage Study Put on Clinical Hold

From Bloomberg Apr 15, 2024

Neumora Therapeutics Inc. fell in premarket trading after US regulators put a clinical hold on an early-stage study of its brain disease treatment following new data linking the therapy to convulsions in rabbits.

Biggest stock movers today: Ansys, Rocket Lab, Nike, Cummins, NetEase (NASDAQ:ANSS)

From Seeking Alpha Dec 22, 2023

Take a look at some of today's biggest stock gainers and losers, including Ansys (ANSS), Karuna Therapeutics (KRTX), Nike (NKE), NetEase (NTES) and AAR (AIR).

Neumora Therapeutics GAAP EPS of -$1.14 misses by $0.74 (NASDAQ:NMRA)

From Seeking Alpha Nov 1, 2023

Neumora Therapeutics press release (NASDAQ:NMRA): Q3 GAAP EPS of -$1.14 misses by $0.74.$519.5 million in cash, cash equivalents and marketable securities...

Why Shares of Neumora Therapeutics Slumped This Week

From The Motley Fool Sep 21, 2023

The clinical-stage biotech just had its IPO last week.

Neumora Therapeutics stock dips following $250M IPO (NMRA)

From Seeking Alpha Sep 15, 2023

Neumora Therapeutics (NMRA) stock dipped 4% in late afternoon trading Friday following a $250M IPO.

Brain disease biotech Neumora Therapeutics (Pending:NMRA)

From Seeking Alpha Sep 15, 2023

The Watertown, MA-based Neumora Therapeutics (NMRA), a Phase 3 biotech developing therapies for brain diseases has priced its initial public offering of 14.71 million shares of its...

ADVERTISEMENT